Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Anthem, Inc.    ANTM

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The company shows low valuation levels, with an enterprise value at 0.77 times its sales.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 310.48.
  • The stock is close to a major daily resistance at USD 307.74, which should be gotten rid of so as to gain new appreciation potential.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Managed Healthcare - NEC
1st jan.Capitalisation (M$)Investor Rating
ANTHEM, INC.-1.39%75 516
UNITEDHEALTH GROUP1.63%283 415
CIGNA CORPORATION7.75%82 083
HUMANA2.55%49 652
CENTENE CORPORATION3.29%38 000
WELLCARE HEALTH PLANS5.97%17 611
-
MOLINA HEALTHCARE, INC.6.85%8 815
MAGELLAN HEALTH, INC.-6.98%1 781
More Results
Financials (USD)
Sales 2020 117 B
EBIT 2020 8 387 M
Net income 2020 5 504 M
Debt 2020 14 634 M
Yield 2020 1,27%
P/E ratio 2020 13,8x
P/E ratio 2021 12,0x
EV / Sales2020 0,77x
EV / Sales2021 0,69x
Capitalization 75 516 M
Upcoming event on ANTHEM, INC.
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes